What's in Serafino A. Marsico's pipeline?

Serafino A. Marsico has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Serafino A. Marsico's portfolio?

Top competitors by shared drug class: Imam Khomeini Hospital, Medical University of South Carolina, The Aurum Institute NPC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/serafino-a-marsico.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Serafino A. Marsico — Portfolio Competitive Intelligence Brief

Serafino A. Marsico pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Inhaled Reduced Glutathione	Inhaled Reduced Glutathione	phase 3	Antioxidant / Mucolytic agent	Glutathione (endogenous antioxidant system)	Respiratory / Pulmonary

Therapeutic area mix

Respiratory / Pulmonary · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Imam Khomeini Hospital · 1 shared drug class
Medical University of South Carolina · 1 shared drug class
The Aurum Institute NPC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Serafino A. Marsico:

Cite this brief

Drug Landscape (2026). Serafino A. Marsico — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/serafino-a-marsico. Accessed 2026-05-16.